Pulse Biosciences, Inc. PLSE Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s investing cash flow?
- Pulse Biosciences, Inc. (PLSE) reported investing cash flow of -$33K in Q1 2026.
- How has Pulse Biosciences, Inc.'s investing cash flow changed year-over-year?
- Pulse Biosciences, Inc.'s investing cash flow increased by 26.7% year-over-year, from -$45K to -$33K.
- What is the long-term trend for Pulse Biosciences, Inc.'s investing cash flow?
- Over 3 years (2022 to 2025), Pulse Biosciences, Inc.'s investing cash flow has grown at a -5.8% compound annual growth rate (CAGR), from -$401K to -$335K.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.